|
Cell Genesys
recipient plasmid pkc(ro − )mnd.mcs Recipient Plasmid Pkc(ro − )Mnd.Mcs, supplied by Cell Genesys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recipient plasmid pkc(ro − )mnd.mcs/product/Cell Genesys Average 90 stars, based on 1 article reviews
recipient plasmid pkc(ro − )mnd.mcs - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
PermeGear Inc
franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml Franz Cell System With Orifice Diameter Of 5mm And Recipient Chamber Volume Of 1.5ml, supplied by PermeGear Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml/product/PermeGear Inc Average 90 stars, based on 1 article reviews
franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
cd8 + t cells from cell cultures or transplant recipients ![]() Cd8 + T Cells From Cell Cultures Or Transplant Recipients, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd8 + t cells from cell cultures or transplant recipients/product/Becton Dickinson Average 90 stars, based on 1 article reviews
cd8 + t cells from cell cultures or transplant recipients - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Vereinigte Papierwarenfabriken GmbH
donor antigen specific regulatory t cell function and outcome in kidney transplant recipients ![]() Donor Antigen Specific Regulatory T Cell Function And Outcome In Kidney Transplant Recipients, supplied by Vereinigte Papierwarenfabriken GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/donor antigen specific regulatory t cell function and outcome in kidney transplant recipients/product/Vereinigte Papierwarenfabriken GmbH Average 90 stars, based on 1 article reviews
donor antigen specific regulatory t cell function and outcome in kidney transplant recipients - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Lechler GmbH
anti-recipient alloreactive t cell precursors ![]() Anti Recipient Alloreactive T Cell Precursors, supplied by Lechler GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti-recipient alloreactive t cell precursors/product/Lechler GmbH Average 90 stars, based on 1 article reviews
anti-recipient alloreactive t cell precursors - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Biomodels LLC
pp152 dual transgenic marker-tolerant mouse model for cell tracking in immunocompetent recipients ![]() Pp152 Dual Transgenic Marker Tolerant Mouse Model For Cell Tracking In Immunocompetent Recipients, supplied by Biomodels LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pp152 dual transgenic marker-tolerant mouse model for cell tracking in immunocompetent recipients/product/Biomodels LLC Average 90 stars, based on 1 article reviews
pp152 dual transgenic marker-tolerant mouse model for cell tracking in immunocompetent recipients - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Wolters Kluwer Health
allo haematopoietic cell transplant recipients ![]() Allo Haematopoietic Cell Transplant Recipients, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/allo haematopoietic cell transplant recipients/product/Wolters Kluwer Health Average 86 stars, based on 1 article reviews
allo haematopoietic cell transplant recipients - by Bioz Stars,
2026-06
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 expression in WT CD8+ T cells is positively correlated with the production of effector molecules. Splenocytes from WT B6 mice were stimulated with 2 µg/ml soluble anti‐CD3e mAb for 24 h, followed by flow cytometric analysis. All contour plots were gated on living CD8+ T cells. (A) Schematic of the experimental design. (B,C) Representative contour plots and bar graphs display the IRF4 expression of CD127+KLRG1−, CD127−KLRG1− and CD127−KLRG1+ CD8+ T‐cell subsets. (D,E) Representative contour plots and bar graphs show the expression of IFN‐γ and granzyme B in CD8+ T‐cell subpopulations that express high, medium or low levels of IRF4. Data are mean ± SD (n = 5). **p < 0.01, ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells are capable of recognizing BALB/c alloantigens. Irf4‐deficient or control CD8+ T cells were stimulated by B6 or BALB/c APCs for 72 h, supplemented with or without murine IL‐2. All contour plots were gated on the living CD8+ T cells. (A,B) % CD62L−CD44+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. (C,D) % CD69+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. (E,F) % Nur77+Ki67+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. Data are mean ± SD (n = 5). ns, no significance; **p < 0.01, ****p < 0.0001 (unpaired Student's t‐test). APC, antigen‐presenting cell
Article Snippet: In brief,
Techniques:
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deletion in CD8+ T cells abrogates their function in rejecting skin allografts. Lymphopenic B6.Rag1−/− recipients were adoptively transferred with either 5 × 105 Irf4‐deficient CD8+ T cells isolated from Irf4 fl/fl Cd4‐Cre mice, or 5 × 105 control CD8+ T cells obtained from Irf4 fl/fl mice. One day later, B6.Rag1−/− recipients were transplanted with fully MHC‐mismatched skin allografts from BALB/c donors. (A) Schematic of the experimental design. Tx, transplantation. (B) The percentage of graft survival post‐allogeneic tail skin transplantation (n = 5). **p < 0.01; Mann–Whitney test. (C) Representative images of a rejected skin graft on a recipient that received control CD8+ T cells (left image), and accepted skin grafts on recipients that received Irf4‐deficient CD8+ T cells (middle and right images) at indicated days post‐skin grafting
Article Snippet: In brief,
Techniques: Isolation, Transplantation Assay, MANN-WHITNEY
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deletion in CD8+ T cells completely abolishes their terminal effector differentiation in transplant recipients. B6.Rag1−/− recipients were adoptively transferred with either Irf4‐deficient (Irf4 fl/fl Cd4‐Cre) or control (Irf4 fl/fl) CD8+ T cells, followed by BALB/c skin transplantation. Adoptively transferred CD8+ T cells in spleens and DLNs were analysed at day 14 post‐skin grafting. All contour plots were gated on the living transferred CD8+ T cells. (A,B) Representative contour plots and bar graph display the % CD127−KLRG1+ terminal effector cells among the transferred CD8+ T cells. (C,D), Representative contour plots and bar graph display the % CD62L−CX3CR1+ effector cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Transplantation Assay
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells barely produce proinflammatory cytokines and cytotoxic molecules in transplant recipients. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All contour plots were gated on the living transferred CD8+ T cells. (A,B) % IFN‐γ+ TNF‐α+ cells among the transferred CD8+ T cells in spleens and DLNs. (C,D) Percentage of granzyme B+ cells among the transferred CD8+ T cells in spleens and DLNs. (E,F) % IL‐2+ and % granzyme A+ cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). *p < 0.05; **p < 0.01, ***p < 0.001; ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques:
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells exhibit low frequency and low Ki67 expression in transplant recipients. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All contour plots and overlay histograms were gated on the living transferred CD8+ T cells in spleens. (A,B) Representative plots and bar graph display the percentage of the transferred CD8+ T cells among CD45+ immune cells. (C‐D) Representative plots and bar graphs display MFI Ki67 among the transferred CD8+ T cells. Data are mean ± SD (n = 3). **p < 0.01 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deficiency in CD8+ T cells affects the expression of key transcription factors that control terminal effector differentiation. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All overlay histograms and contour plots were gated on the living transferred CD8+ T cells in spleens. Representative overlay histograms and bar graphs show T‐bet (A,B) and ID2 (C,D) expression levels of the transferred CD8+ T cells. Representative contour plots and bar graphs show % TCF1+ (E,F) and % EOMES+ (G,H) cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). *p < 0.05; **p < 0.01, ***p < 0.001; (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Naïve Irf4‐deficient CD8+ T cells barely differentiate into terminal effector cells and fail to reject skin allografts. B6.Rag1−/− recipients were adoptively transferred with naïve Irf4‐deficient or control CD8+ T cells, and transplanted with BALB/c tail skins or left without transplantation. (A) Schematic of the experimental design. (B) Representative contour plots display the purified CD44low naïve CD8 T cells prior to adoptive transfer. (C) The percentage of graft survival post‐transplantation (n = 6). ***p < 0.001; Mann–Whitney test. (D) Representative H&E staining images (×200) of the skin grafts on recipients that received naïve control (left image) or naïve Irf4‐deficient (right image) CD8+ T cells at day 14 post‐grafting. (E,F) Representative contour plots and graphs show % CD8+ cells among CD45.2+ immune cells, and the absolute number of CD8+ cells in spleens on day 14 post‐grafting. (G,H) Representative contour plots and the graph display % CD127−KLRG1+ cells among the transferred CD8+ T cells. Data are mean ± SD (n = 4). ns, no significance; *p < 0.05; ***p < 0.001; ****p< 0.0001 (unpaired Student's t‐test). Tx, transplantation
Article Snippet: In brief,
Techniques: Transplantation Assay, Purification, Adoptive Transfer Assay, MANN-WHITNEY, Staining
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells fail to acquire terminal effector phenotypes in recipients with long‐term accepted allografts. B6.Rag1−/− recipients were adoptively transferred with either Irf4‐deficient or control CD8+ T cells, followed by BALB/c skin transplantation. Adoptively transferred CD8+ T cells in spleens were analysed by flow cytometry at day 100 post‐skin grafting. (A,B) Representative contour plots and bar graphs show % CD8+ T cells among CD45.2+ immune cells (A,B left bar graph), and absolute CD8+ T cells in spleens (B right bar graph). (C‐J) Contour plots were gated on the living transferred CD8+ T cells in spleens. Representative contour plots and bar graphs show % CD127−KLRG1+ (C,D), CD62L−CX3CR1+ (E,F), IFN‐γ+ (G,H), TCF1+ (I,J left bar graph) and EOMES+ (i,j right bar graph) cells among the adoptively transferred CD8+ T cells. Data are mean ± SD of n ≥ 3 animals per group. ns, no significance; *p < 0.05; **p < 0.01; ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Transplantation Assay, Flow Cytometry